Abstract |
S-carboxymethylcysteine (S-CMC) has been used as a mucoregulator in respiratory diseases. However, the mechanism of action of S-CMC on allergic airway inflammation has not yet been defined. In the present study, BALB/c mice were initially sensitised and challenged to ovalbumin (OVA) and, weeks later, re-challenged with OVA (secondary challenge). S-CMC (5-100 mg.kg-1) was administered from 2 days before the secondary challenge through to the day of assay. Mice developed airway hyperresponsiveness (AHR) 6 h after the secondary challenge and increased numbers of neutrophils were present in the bronchoalveolar lavage (BAL) fluid. At 72 h after secondary challenge, mice again developed AHR, but the BAL fluid contained large numbers of eosinophils. S-CMC treatment was found to reduce AHR and neutrophilia at 6 h, as well as eosinophilia and AHR at 72 h. These effects appeared to be dose dependent. Goblet cell hyperplasia, observed at 72 h, was reduced by S-CMC. In BAL fluid, increased levels of interferon-gamma, interleukin (IL)-12 and IL-10 and decreased levels of IL-5 and IL-13 were detected. In conclusion, the data indicate that S-carboxymethylcysteine is effective in reducing airway hyperresponsiveness and airway inflammation at two distinct phases of the response to the secondary allergen challenge in sensitised mice.
|
Authors | K Takeda, N Miyahara, T Kodama, C Taube, A Balhorn, A Dakhama, K Kitamura, A Hirano, M Tanimoto, E W Gelfand |
Journal | The European respiratory journal
(Eur Respir J)
Vol. 26
Issue 4
Pg. 577-85
(Oct 2005)
ISSN: 0903-1936 [Print] England |
PMID | 16204586
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Allergens
- Anti-Inflammatory Agents
- Cytokines
- Carbocysteine
- Ovalbumin
|
Topics |
- Allergens
(adverse effects)
- Animals
- Anti-Inflammatory Agents
(immunology, therapeutic use)
- Bronchial Hyperreactivity
(drug therapy, immunology)
- Bronchoalveolar Lavage Fluid
(chemistry)
- Carbocysteine
(immunology, therapeutic use)
- Cytokines
(analysis)
- Disease Models, Animal
- Female
- Mice
- Mice, Inbred BALB C
- Ovalbumin
(adverse effects)
|